A survey study of pregnant women and healthcare practitioners assessing the knowledge of attitudes and practices of hepatitis B management at a teaching hospital in Kumasi, Ghana, West Africa

Open Forum Infectious Diseases

Volumn 2, Issue 4, 2015, Pages 1-3

  Cheng, Anita ^a   Jose, JoAnn ^a   Larsen Reindorf, Roderick ^b   Small, Christina ^a   Nde, Helen ^a   Dugas, Lara ^a   Ehrhardt, Stephan ^c   Nelson, Kenrad ^c   Ezeanolue, Eche ^d   Layden, Jennifer ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b KOMFO ANOKYE TEACHING HOSPITAL   (Ghana)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; TENOFOVIR;

ANONYMISED DATA; ARTICLE; ATTITUDE TO HEALTH; FEMALE; GHANA; GYNECOLOGIST; HEALTH CARE COST; HEALTH CARE SURVEY; HEPATITIS B; HUMAN; PREGNANT WOMAN; PRIORITY JOURNAL; QUESTIONNAIRE; TEACHING HOSPITAL; UNPROTECTED SEX; VACCINATION; VIRUS INFECTION; VIRUS TRANSMISSION;

EID: 85014059614     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofv122     Document Type: Article

References (10)

1. World Health Organization. Hepatitis B Fact Sheet. http://www.who. int/mediacentre/factsheets/fs204/en/, 2031.
2. Custer B, Sullivan SD, Hazlet TK, et al. Global epidemiology of hepatitis B virus. J Clin Gastroenterol 2004; 38:S158-68.
3. Edmunds WJ, Medley GF, Nokes DJ, et al. The influence of age on the development of the hepatitis B carrier state. Proc Biol Sci 1993; 253:197-201.
4. Chen HL, Lee CN, Chang CH, et al. Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus. Hepatology 2015; 62:375-86.
5. Greenup AJ, Tan PK, Nguyen V, et al. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus. J Hepatol 2014; 61:502-7.
6. Tsai PJ, Chang A, Yamada S, et al. Use of tenofovir disoproxil fumarate in highly viremic, hepatitis B mono-infected pregnant women. Dig Dis Sci 2014; 59:2797-803.
7. Jackson V, Ferguson W, Kelleher TB, et al. Lamivudine treatment and outcome in pregnant women with high hepatitis B viral loads. Eur J Clin Microbiol Infect Dis 2015; 34:619-23.
8. Chan OK, Lao TT, Suen SS, Leung TY. Deficient knowledge on hepatitis B infection in pregnant women and prevalence of hepatitis B surface antigen carriage in an endemic area: a review. Hepat Res Treat 2012; doi:10.1155/2012/317451.
9. Frambo AA, Atashili J, Fon PN, Ndumbe PM. Prevalence of HBsAg and knowledge about hepatitis B in pregnancy in the Buea Health District, Cameroon: a cross-sectional study. BMC Res Notes 2014; 7:394.
10. Adibi P, Zavareh J, Mohseni M, Zamani A. Attitudes towards maternal screening for hepatitis B virus infection in Iran. Trop Gastroenterol 2010; 31:180-3.